DiBattista, Amanda M.

Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease

Sung, Y. M., Lee, T., Yoon, H., DiBattista, A. M., Song, J. M., Sohn, Y., Moffat, E. I., Turner, R. S., Jung, M., Kim, J., et al. (2013) · Experimental Neurology

Alzheimer's disease research and treatmentsHistone Deacetylase Inhibitors Research

Cited by 137

NIH SenNet Consortium to map senescent cells throughout the human lifespan to understand physiological health.

SenNet Consortium, Writing Group, Lee, P. J., Benz, C. C., Blood, P., Börner, K., Campisi, J., Chen, F., Daldrup-Link, H., De Jager, P., et al. (2022) · Nature Aging

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 122

APOE genotype affects the pre‐synaptic compartment of glutamatergic nerve terminals

Dumanis, S. B., DiBattista, A. M., Miessau, M., Moussa, C. E. H., & Rebeck, G. W. (2013) · Journal of Neurochemistry

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 55

NIA workshop on senescence in brain aging and Alzheimer's disease and its related dementias

DiBattista, A. M., Sierra, F., & Masliah, E. (2020) · GeroScience

Telomeres, Telomerase, and SenescenceAlzheimer's disease research and treatments

Cited by 16